$26.17
-0.81[-3.00%]
At close: Apr 25
$26.17
0[0.00%]
After Hours: 4:20PM EDT
Arcturus Therapeutics
(NASDAQ:ARCT)Latest News for Arcturus Therapeutics Stock (NASDAQ:ARCT)
Arcturus Therapeutics Stock (NASDAQ: ARCT)
Categories: All
Wednesday, March 20, 2024
Monday, March 11, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
- Recap: Arcturus Therapeutics Q4 EarningsBenzinga Insights - Mar 7, 2024, 4:05PM
- Arcturus Therapeutics Q4 2023 GAAP EPS $(0.320) Beats $(0.760) Estimate, Sales $33.989M Miss $37.856M EstimateBenzinga Newsdesk - Mar 7, 2024, 4:03PM
- Earnings Scheduled For March 7, 2024Benzinga Insights - Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
Thursday, February 22, 2024
Thursday, February 08, 2024
Monday, February 05, 2024
Tuesday, January 23, 2024
Thursday, December 21, 2023
Wednesday, December 13, 2023
Monday, December 04, 2023
Tuesday, November 28, 2023
Monday, November 27, 2023
Wednesday, November 15, 2023
- Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 15, 2023, 2:04PM
- Arcturus Therapeutics shares are trading higher after the company reported Q3 financial results.Benzinga Newsdesk - Nov 15, 2023, 12:35PM
- Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On WednesdayLisa Levin - Nov 15, 2023, 11:08AM
- HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price TargetBenzinga Newsdesk - Nov 15, 2023, 10:37AM
- Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 15, 2023, 8:07AM
Tuesday, November 14, 2023
- Arcturus Therapeutics: Q3 Earnings InsightsBenzinga Insights - Nov 14, 2023, 4:45PM
- Arcturus Therapeutics shares are trading higher after the company reported Q3 financial results.Benzinga Newsdesk - Nov 14, 2023, 4:37PM
- Arcturus Therapeutics Q3 EPS $(0.61) vs $(1.33) YoYBenzinga Newsdesk - Nov 14, 2023, 4:02PM
- Earnings Scheduled For November 14, 2023Benzinga Insights - Nov 14, 2023, 8:23AM
Wednesday, October 04, 2023
Monday, October 02, 2023
Wednesday, September 27, 2023
Wednesday, September 20, 2023
Tuesday, September 19, 2023
Tuesday, September 05, 2023
- HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price TargetBenzinga Newsdesk - Sep 5, 2023, 12:11PM
- Arcturus Therapeutics And CSL Announce European Medicines Agency Validates Marketing Authorization Application For ARCT-154 Vaccine To Prevent COVID-19Happy Mohamed - Sep 5, 2023, 8:45AM
Tuesday, August 22, 2023
Tuesday, August 15, 2023
Monday, August 14, 2023
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Aug 8, 2023, 1:31PM
- Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Aug 8, 2023, 1:13PM
- Arcturus Therapeutics Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga Newsdesk - Aug 8, 2023, 12:14PM
- HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price TargetBenzinga Newsdesk - Aug 8, 2023, 6:30AM
Monday, August 07, 2023
Monday, July 24, 2023
- Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite CompetitionVandana Singh - Jul 24, 2023, 1:17PM
- Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023Benzinga Insights - Jul 24, 2023, 11:00AM
- William Blair Initiates Coverage On Arcturus Therapeutics with Outperform Rating, Announces Price Target of $71Benzinga Newsdesk - Jul 24, 2023, 9:13AM